Correlation Between Inhibikase Therapeutics and Kaleido Biosciences

Can any of the company-specific risk be diversified away by investing in both Inhibikase Therapeutics and Kaleido Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibikase Therapeutics and Kaleido Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Inhibikase Therapeutics and Kaleido Biosciences, you can compare the effects of market volatilities on Inhibikase Therapeutics and Kaleido Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibikase Therapeutics with a short position of Kaleido Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibikase Therapeutics and Kaleido Biosciences.

Diversification Opportunities for Inhibikase Therapeutics and Kaleido Biosciences

0.0

Correlation Coefficient

Inhibikase Therapeutics  Kaleido Biosciences

Pay attention - limited upside

The 3 months correlation between Inhibikase and Kaleido is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Inhibikase Therapeutics and Kaleido Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kaleido Biosciences and Inhibikase Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibikase Therapeutics are associated (or correlated) with Kaleido Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kaleido Biosciences has no effect on the direction of Inhibikase Therapeutics i.e., Inhibikase Therapeutics and Kaleido Biosciences go up and down completely randomly.

Pair Corralation between Inhibikase Therapeutics and Kaleido Biosciences

If you would invest  276.00  in Inhibikase Therapeutics on December 1, 2024 and sell it today you would lose (46.00) from holding Inhibikase Therapeutics or give up 16.67% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Inhibikase Therapeutics  vs.  Kaleido Biosciences

Inhibikase Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Inhibikase Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable forward-looking signals, Inhibikase Therapeutics is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Kaleido Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Kaleido Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, Kaleido Biosciences is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Inhibikase Therapeutics and Kaleido Biosciences

The main advantage of trading using opposite Inhibikase Therapeutics and Kaleido Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibikase Therapeutics position performs unexpectedly, Kaleido Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kaleido Biosciences will offset losses from the drop in Kaleido Biosciences' long position.

The idea behind Inhibikase Therapeutics and Kaleido Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.